Michael Patrick  Donovan net worth and biography

Michael Donovan Biography and Net Worth

VP of AxoGen
Mr. Donovan has served as Vice President of Operations for Axogen since September 2015. Prior to this he was the Director of Operations of Axogen, Inc. from November 2011 and of Axogen Corporation from January 2011 to September 2015. From 1988 to 2010, Mike held positions at Zimmer Holdings in manufacturing, continuous improvement, quality assurance and sterilization, including director of manufacturing from 2002 to 2010. Mike has a B.S. in chemical engineering and an MBA from the University of Akron.

What is Michael Patrick Donovan's net worth?

The estimated net worth of Michael Patrick Donovan is at least $519,350.64 as of March 21st, 2024. Mr. Donovan owns 37,992 shares of AxoGen stock worth more than $519,351 as of October 6th. This net worth approximation does not reflect any other assets that Mr. Donovan may own. Learn More about Michael Patrick Donovan's net worth.

How do I contact Michael Patrick Donovan?

The corporate mailing address for Mr. Donovan and other AxoGen executives is 13631 PROGRESS BLVD. SUITE 400, ALACHUA FL, 32615. AxoGen can also be reached via phone at (386) 462-6800 and via email at [email protected]. Learn More on Michael Patrick Donovan's contact information.

Has Michael Patrick Donovan been buying or selling shares of AxoGen?

Michael Patrick Donovan has not been actively trading shares of AxoGen during the last quarter. Most recently, Michael Patrick Donovan sold 6,033 shares of the business's stock in a transaction on Thursday, March 21st. The shares were sold at an average price of $7.68, for a transaction totalling $46,333.44. Following the completion of the sale, the vice president now directly owns 37,992 shares of the company's stock, valued at $291,778.56. Learn More on Michael Patrick Donovan's trading history.

Who are AxoGen's active insiders?

AxoGen's insider roster includes Michael Donovan (VP), Maria Martinez (Insider), and Karen Zaderej (CEO). Learn More on AxoGen's active insiders.

Are insiders buying or selling shares of AxoGen?

In the last twelve months, insiders at the medical equipment provider sold shares 6 times. They sold a total of 123,701 shares worth more than $1,021,803.98. The most recent insider tranaction occured on March, 21st when CEO Karen L Zaderej sold 39,280 shares worth more than $301,670.40. Insiders at AxoGen own 7.0% of the company. Learn More about insider trades at AxoGen.

Information on this page was last updated on 3/21/2024.

Michael Patrick Donovan Insider Trading History at AxoGen

Transaction DateBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
3/21/2024Sell6,033$7.68$46,333.4437,992View SEC Filing Icon  
3/7/2024Sell36,310$8.81$319,891.1035,708View SEC Filing Icon  
7/21/2021Sell1,935$20.04$38,777.4040,839View SEC Filing Icon  
11/9/2020Sell17,617$15.00$264,255.0026,029View SEC Filing Icon  
6/13/2019Sell20,000$20.00$400,000.0018,974View SEC Filing Icon  
See Full Table

Michael Patrick Donovan Buying and Selling Activity at AxoGen

This chart shows Michael Patrick Donovan's buying and selling at AxoGen by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

AxoGen Company Overview

AxoGen logo
AxoGen, Inc., together with its subsidiaries, develops and commercializes technologies for peripheral nerve regeneration and repair worldwide. The company's products include Avance Nerve Graft, a biologically active off-the-shelf processed human nerve allograft for bridging severed peripheral nerves without the comorbidities associated with a second surgical site; AxoGuard Nerve Connector, a porcine submucosa extracellular matrix (ECM) coaptation aid for tensionless repair of severed peripheral nerves; AxoGuard Nerve Protector, a porcine submucosa ECM product that is used to wrap and protect damaged peripheral nerves, as well as reinforces the nerve reconstruction while preventing soft tissue attachments; and Axoguard HA+ Nerve Protector, a processed porcine submucosa ECM base layer with a hyaluronate-alginate gel coating designed to provide short- and long-term protection for peripheral nerve injuries. Its products also comprise Axoguard Nerve Cap, a porcine submucosa ECM product that is used to protect a peripheral nerve end, as well as separates the nerve from the surrounding environment to reduce the development of symptomatic or painful neuroma; and AxoTouch two-point discriminator, a tool that is used for measuring the innervation density of surface area of the skin. The company provides its products to hospitals, surgery centers, and military hospitals, plastic reconstructive surgeons, orthopedic and plastic hand surgeons, and various oral and maxillofacial surgeons. AxoGen, Inc. is headquartered in Alachua, Florida.
Read More

Today's Range

Now: $13.67
Low: $13.33
High: $13.81

50 Day Range

MA: $12.29
Low: $7.80
High: $14.69

2 Week Range

Now: $13.67
Low: $3.45
High: $15.08

Volume

260,201 shs

Average Volume

401,818 shs

Market Capitalization

$597.45 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.13